Our results reveal that panduratin A decreased cell proliferation by attenuating the activity of p70/S6K, which is a downstream target of mTOR signaling pathways in both MDCK and ADPKD cells. The gene discussed is RPS6KB1; the disease is autosomal dominant polycystic kidney disease.